Matthew Caufield
Stock Analyst at HC Wainwright & Co.
(0.91)
# 2,782
Out of 4,412 analysts
54
Total ratings
28.85%
Success rate
-24.21%
Average return
Main Sectors:
12 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LYRA Lyra Therapeutics | Reiterates: Buy | $12 | $5.16 | +132.56% | 4 | May 1, 2024 | |
| ADVM Adverum Biotechnologies | Initiates: Buy | $30 | $9.72 | +208.64% | 1 | Apr 30, 2024 | |
| OPTN OptiNose | Reiterates: Buy | $5 | $0.82 | +509.01% | 3 | Apr 29, 2024 | |
| ALDX Aldeyra Therapeutics | Reinstates: Buy | $10 | $3.94 | +153.81% | 7 | Apr 2, 2024 | |
| HLVX HilleVax | Reiterates: Buy | $28 | $13.20 | +112.12% | 2 | Mar 21, 2024 | |
| EYEN Eyenovia | Reiterates: Buy | $12 | $0.75 | +1,497.87% | 9 | Mar 19, 2024 | |
| OCUP Ocuphire Pharma | Reiterates: Buy | $20 | $1.59 | +1,161.83% | 7 | Mar 11, 2024 | |
| PHAT Phathom Pharmaceuticals | Reiterates: Buy | $28 | $9.03 | +210.08% | 3 | Mar 8, 2024 | |
| FDMT 4D Molecular Therapeutics | Reiterates: Buy | $36 | $23.93 | +50.44% | 10 | Mar 1, 2024 | |
| UBX Unity Biotechnology | Reiterates: Buy | $10 | $1.54 | +549.35% | 4 | Nov 14, 2023 | |
| FN Fabrinet | Reiterates: Buy | $28 | $173.07 | -83.82% | 1 | Aug 22, 2023 | |
| OPT Opthea | Reiterates: Buy | $14 | $3.34 | +319.16% | 3 | Aug 1, 2023 |
Lyra Therapeutics
May 1, 2024
Reiterates: Buy
Price Target: $12
Current: $5.16
Upside: +132.56%
Adverum Biotechnologies
Apr 30, 2024
Initiates: Buy
Price Target: $30
Current: $9.72
Upside: +208.64%
OptiNose
Apr 29, 2024
Reiterates: Buy
Price Target: $5
Current: $0.82
Upside: +509.01%
Aldeyra Therapeutics
Apr 2, 2024
Reinstates: Buy
Price Target: $10
Current: $3.94
Upside: +153.81%
HilleVax
Mar 21, 2024
Reiterates: Buy
Price Target: $28
Current: $13.20
Upside: +112.12%
Eyenovia
Mar 19, 2024
Reiterates: Buy
Price Target: $12
Current: $0.75
Upside: +1,497.87%
Ocuphire Pharma
Mar 11, 2024
Reiterates: Buy
Price Target: $20
Current: $1.59
Upside: +1,161.83%
Phathom Pharmaceuticals
Mar 8, 2024
Reiterates: Buy
Price Target: $28
Current: $9.03
Upside: +210.08%
4D Molecular Therapeutics
Mar 1, 2024
Reiterates: Buy
Price Target: $36
Current: $23.93
Upside: +50.44%
Unity Biotechnology
Nov 14, 2023
Reiterates: Buy
Price Target: $10
Current: $1.54
Upside: +549.35%
Fabrinet
Aug 22, 2023
Reiterates: Buy
Price Target: $28
Current: $173.07
Upside: -83.82%
Opthea
Aug 1, 2023
Reiterates: Buy
Price Target: $14
Current: $3.34
Upside: +319.16%